Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.
Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]
Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a "buy" rating on the stock.